文献速递神经肿瘤小儿神经外科与脑积水神经重症

软脑膜疾病背景下脑脊液分流术后病程:系统评价、Meta分析及Meta回归并附一例说明性病例

Postoperative course of cerebrospinal fluid diversion in the setting of leptomeningeal disease: a systematic review, meta-analysis, and meta-regression with an illustrative case.
PubMed 文献 · J Neurooncol · 2023-05-16

该系统评价与Meta分析检索至2023年3月的多个数据库,纳入12项研究、503例软脑膜疾病(LMD)患者,其中442例(88%)行脑室腹腔分流(VPS)、61例(12%)行腰腹腔分流(LPS)。Meta分析显示分流术后症状缓解的合并发生率为79%(95%CI 68-88%),需分流修正者为10%(95%CI 6-15%),分流术后总生存期为3.8个月(95%CI 2.9-4.6个月)。

要点

  • LMD患者脑脊液分流术后症状缓解合并发生率为79%(95%CI 68-88%)。
  • 分流修正的合并发生率为10%(95%CI 6-15%)。
  • 分流术后中位总生存期为3.8个月(95%CI 2.9-4.6个月)。

核心结论

  • LMD背景下脑脊液分流可改善多数患者脑积水症状,但仍有不可忽视比例需分流修正。
  • 术后LMD预后仍差,与分流类型无关,指数手术后预期中位总生存期为数月。
  • 这些发现支持将脑脊液分流作为考虑症状与生活质量时的有效姑息性手术。
  • 需进一步研究以了解如何管理术后预期,尊重患者、家属及治疗团队的最佳意愿。

研究设计与样本

  • 遵循PRISMA指南检索多个电子数据库自建库至2023年3月。
  • 共纳入12项研究,描述503例经脑脊液分流管理的LMD患者,其中442例(88%)行VPS、61例(12%)行LPS。
  • 采用随机效应模型进行Meta分析与Meta回归,并对所有结局进行事后偏倚评估。

主要发现

  • 分流男性百分比与分流时年龄的中位数分别为32%和58岁,肺癌与乳腺癌为最常见原发诊断。
  • Meta分析显示指数分流术后症状缓解的合并发生率为79%(95%CI 68-88%)。
  • 需分流修正的合并发生率为10%(95%CI 6-15%)。
  • 所有研究中指数分流术后合并总生存期为3.8个月(95%CI 2.9-4.6个月)。
  • Meta回归显示发表较晚的研究趋向于指数分流术后总生存期显著更短(系数=-0.38,P=0.023),而各研究中VPS与LPS的比例不影响生存(P=0.89)。

关键数值与推荐

  • 症状缓解合并发生率79%(95%CI 68-88%)。
  • 分流修正合并发生率10%(95%CI 6-15%)。
  • 指数分流术后合并总生存期3.8个月(95%CI 2.9-4.6个月)。
  • 考虑偏倚后重新估计总生存期3.1个月(95%CI 1.7-4.4个月)。
  • 发表较晚研究的总生存期系数=-0.38,P=0.023;VPS与LPS比例对生存影响P=0.89。

临床怎么用

  • 原文结论支持将脑脊液分流作为考虑症状与生活质量时的有效姑息性手术。
  • 作者指出需进一步研究以了解如何管理术后预期,尊重患者、家属及治疗团队的最佳意愿。

局限性

  • 原文报告发表较晚的研究趋向于指数分流术后总生存期显著更短(系数=-0.38,P=0.023)。
  • 原文报告各研究中VPS与LPS的比例不影响生存(P=0.89)。
  • 原文报告考虑这些偏倚后总生存期重新估计为更短的3.1个月(95%CI 1.7-4.4个月)。
  • 原文指出当前文献可能存在偏倚。
  • 原文结论指出需进一步研究以了解如何管理术后预期。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Management of hydrocephalus symptoms in the setting of leptomeningeal disease (LMD) includes cerebrospinal fluid (CSF) diversion, which can in the form of ventriculoperitoneal shunting (VPS) and lumboperitoneal shunting (LPS). However, the quantifiable postoperative course following this intervention is poorly defined. Correspondingly the aim of our study was to quantitatively define and analyze the pooled metadata regarding this topic. METHODS: Multiple electronic databases from inception to March 2023 were searched following PRISMA guidelines. Respective cohort-level outcomes were then abstracted and pooled by means of meta-analyses and analyzed by means meta-regression, both utilizing random-effects modeling. Post-hoc bias evaluation was then performed for all outcomes. RESULTS: A total of 12 studies were identified for inclusion, describing 503 LMD patients managed by CSF diversion - 442 (88%) by VPS and 61 (12%) by LPS. Median male percentage and age at diversion were 32% and 58 years respectively, with lung and breast cancer the most common primary diagnoses. Meta-analysis demonstrated pooled incidence of symptom resolution in 79% (95% CI 68-88%) of patients after index shunt surgery, and shunt revision required in 10% (95% CI 6-15%) of cases. Pooled overall survival from index shunt surgery was 3.8 mo (95% CI 2.9-4.6 mo) across all studies. Meta-regression demonstrated that studies published later trended towards significantly shorter overall survival from index shunt surgery (co-efficient=-0.38, P = 0.023), whereas the proportion of VPS to LPS in each study did not impact survival (P = 0.89). When accounting for these biases, overall survival from index shunt surgery was re-estimated to be shorter 3.1 mo (95% CI 1.7-4.4 mo). We present an illustrative case demonstrating the course of symptom improvement, shunt revision and an overall survival of 2 weeks from index CSF diversion. CONCLUSION: Although CSF diversion in the setting of LMD can improve hydrocephalus symptoms in the majority of patients, there is a non-negligible proportion that will require shunt revision. Postoperatively, the prognosis of LMD remains poor irrespective of shunt type, and despite possible biases within the current literature, the expected median overall survival after index surgery is a matter of months. These findings support CSF diversion as an effective palliative procedure when considering symptoms and quality of life. Further research is required to understand how postoperative expectations can be managed to respect the best wishes of patients, their family, and the treating clinical team.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Lu VM, Abou-Al-Shaar H, Bin-Alamer O, et al. Postoperative course of cerebrospinal fluid diversion in the setting of leptomeningeal disease: a systematic review, meta-analysis, and meta-regression with an illustrative case. J Neurooncol. 2023. PMID: 37191912. doi:10.1007/s11060-023-04334-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。